Today: 29 April 2026
Gold price today: Bullion slides as Warsh Fed pick and CME margin hike hit leveraged bets

Gold price today: Bullion slides as Warsh Fed pick and CME margin hike hit leveraged bets

New York, February 2, 2026, 13:32 EST — Regular session

  • Spot gold fell 3.8%, dipping to around $4,680 per ounce after trading within a $480 intraday range
  • After the close, CME will raise margin requirements for gold futures, increasing cash demands on traders
  • Attention shifts to U.S. jobs data on Feb. 6, the upcoming key indicator for rates and the dollar

Gold slipped again on Monday, with spot bullion dropping 3.8% to roughly $4,679 an ounce by early afternoon in New York. It hit a low of $4,402 earlier. U.S. gold futures also edged down about 0.9%, settling near $4,704.

The sharp sell-off comes after last week’s record highs, marking one of the steepest two-day declines in years. Gold has tumbled about $900 from its late-January peak, with Friday’s drop erasing nearly all of this year’s gains.

Selling accelerated after U.S. President Donald Trump tapped former Federal Reserve governor Kevin Warsh to replace Chair Jerome Powell—a move some saw as a sign of a tougher stance and a boost for the dollar. Vivek Dhar, strategist at Commonwealth Bank of Australia, noted that the sharp sell-off in precious metals and stocks points to investors betting on Warsh being “more hawkish.” Tony Sycamore from IG compared the scale of the sell-off to “the dark days” of 2008. Reuters

Another hit came right after the bell. CME Group announced that performance bond requirements—the margin traders need to hold futures—will increase after Monday’s close. Their notice revealed COMEX 100 gold futures margins jumping from 6% to 8% for standard positions, with even steeper hikes for higher-risk categories.

SP Angel analyst John Meyer described the situation as a “rollercoaster ride,” noting that some funds linked to gold-backed ETFs, which hold physical bullion but trade like stocks, saw outflows. Deutsche Bank’s Michael Hsueh dismissed the idea of a “sustained reversal,” highlighting continued volatility in both positioning and prices. Reuters

Silver dropped more sharply than gold for the second day running, deepening a selloff that has wiped away much of last week’s record gains. Platinum and palladium edged lower too, spreading the weakness across the precious metals sector.

JPMorgan remains bullish on gold’s long-term outlook, predicting central banks and investors will push prices to $6,300 an ounce by the end of 2026. The bank also projects central banks will purchase roughly 800 tons this year.

The near-term outlook remains tangled. Rising margins might trigger further deleveraging, and a stronger dollar would continue to weigh on metals priced in greenbacks. At the same time, any renewed risk spike could swiftly boost safe-haven demand.

After the close, all eyes will be on price moves following the CME margin adjustments, to see if volatility eases or intensifies. The next major macro event is Friday’s U.S. employment report, set for Feb. 6 at 08:30 a.m. ET. Job openings data arrives Tuesday, with U.S. inflation numbers due later this month.

Stock Market Today

  • Mesoblast Shares Falter Amid Growing Uncertainty Over Growth Prospects
    April 28, 2026, 10:58 PM EDT. Mesoblast (ASX:MSB) shares closed at A$2.15, down 6.5% over the past week despite a 0.5% gain in the last day. The biopharma firm shows mixed signals: positive 1- and 3-year shareholder returns contrast with weaker short-term performance. Analysts highlight Mesoblast as 43.9% undervalued with a fair value target of A$3.83, driven by heart failure drug rexlemestrocel L, pending potential U.S. accelerated FDA approval. However, risks loom from slow Ryoncil sales and trial delays. Valuation models conflict; discounted cash flow suggests undervaluation at A$3.05, but a high price-to-sales ratio of 30.5x versus industry norms raises questions if the market overpays for growth or if assumptions are overstretched. Investors remain cautious amid uncertain future earnings and regulatory hurdles.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Previous Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop